Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,025 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Global Epidemiology of Primary Biliary Cholangitis: An Updated Systematic Review and Meta-Analysis.
Tan JJ, Chung AH, Loo JH, et al. · Clin Gastroenterol Hepatol · 2026Systematic Review, Meta-Analysis
- Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, et al. · N Engl J Med · 2024Clinical Trial, Phase III, Multicenter Study
- A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
Hirschfield GM, Bowlus CL, Mayo MJ, et al. · N Engl J Med · 2024Randomized Controlled Trial, Clinical Trial, Phase III
- Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Hirschfield GM, Bowlus CL, Jones DEJ, et al. · Lancet Gastroenterol Hepatol · 2026Randomized Controlled Trial, Multicenter Study
- Second-Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta-Analysis.
Giannini EG, Pasta A, Calabrese F, et al. · Liver Int · 2025Systematic Review, Network Meta-Analysis
- An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Cordell HJ, Fryett JJ, Ueno K, et al. · J Hepatol · 2021Meta-Analysis, Research Support, N.I.H., Extramural
- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
Corpechot C, Chazouillères O, Rousseau A, et al. · N Engl J Med · 2018Clinical Trial, Phase III, Multicenter Study
- Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O, Eliahoo J, Kim JU, et al. · J Hepatol · 2020Research Support, Non-U.S. Gov't, Systematic Review
- A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
Schattenberg JM, Pares A, Kowdley KV, et al. · J Hepatol · 2021Clinical Trial, Phase II, Multicenter Study
- Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis.
Kremer AE, Mayo MJ, Hirschfield GM, et al. · Hepatology · 2024Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Prevalence and Clinical Outcomes of Recompensation in Decompensated Cirrhosis: A Systematic Review and Meta-Analysis.
Goh XE, Goh MX, Chen VL, et al. · Clin Gastroenterol Hepatol · 2026Systematic Review, Meta-Analysis
- Pharmacological Therapy of Pruritus in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Medina-Morales E, Barba Bernal R, Gerger H, et al. · J Clin Gastroenterol · 2023Systematic Review, Meta-Analysis
- Safety profile of elafibranor versus placebo in primary biliary cholangitis: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials.
Khan NA, Shahbaz H, Talha M, et al. · Medicine (Baltimore) · 2026Systematic Review, Meta-Analysis
- Comparative effectiveness of peroxisome proliferator-activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis.
Martins A, Khakoo NS, Reddy A, et al. · Hepatology · 2026Systematic Review, Meta-Analysis
- Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.
Lammers WJ, van Buuren HR, Hirschfield GM, et al. · Gastroenterology · 2014Meta-Analysis, Research Support, Non-U.S. Gov't
- Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver Diseases.
Koc OM, Toussaint AK, Untas A, et al. · Lancet Gastroenterol Hepatol · 2026Consensus Statement, Meta-Analysis
- Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, et al. · Hepatology · 2023Randomized Controlled Trial, Clinical Trial, Phase III
- Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical Trial.
Liu Y, Guo G, Zheng L, et al. · Am J Gastroenterol · 2023Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Osteoporosis and Primary Biliary Cholangitis: A Trans-ethnic Mendelian Randomization Analysis.
Wu Y, Qian Q, Liu Q, et al. · Clin Rev Allergy Immunol · 2024Meta-Analysis, Review
- Primary biliary cholangitis in pregnancy: A systematic review with meta-analysis.
El Jamaly H, Eslick GD, Weltman M · Hepatobiliary Pancreat Dis Int · 2022Meta-Analysis, Systematic Review
- Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
Smith HT, de Souza AR, Thompson AH, et al. · Dig Dis Sci · 2023Systematic Review, Research Support, Non-U.S. Gov't
- Epidemiologic and genetic associations between primary biliary cholangitis and extrahepatic rheumatic diseases.
Qian Q, Wu Y, Cui N, et al. · J Autoimmun · 2024Meta-Analysis, Systematic Review
- GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus.
Levy C, Kendrick S, Bowlus CL, et al. · Clin Gastroenterol Hepatol · 2023Randomized Controlled Trial, Multicenter Study
- COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley KV, Hirschfield GM, Coombs C, et al. · Am J Gastroenterol · 2025Randomized Controlled Trial, Clinical Trial, Phase III
- URSO-panacea or placebo?
Neuberger J · Hepatology · 2000Systematic Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.